Normal aging impairs upregulation of the beta-adrenergic but not the alpha-adrenergic response: Aging and adrenergic upregulation

Journal of Cardiovascular Pharmacology

Volumn 48, Issue 4, 2006, Pages 153-159

  Madden, Kenneth M ^a,c   Levy, Wayne C ^b   Stratton, John R ^b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF WASHINGTON   (United States)

^c VANCOUVER HOSPITAL AND HEALTH SCIENCES CENTRE   (Canada)

Author keywords

Adrenergic alpha agonists; Adrenergic beta agonists; Adrenergic response; Aging; Sympathetic downregulation

Indexed keywords

CLONIDINE; ISOPRENALINE; PHENYLEPHRINE;

ADRENERGIC SYSTEM; ADULT; AGED; AGING; ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DRUG EFFECT; FEMALE; HUMAN; MALE; MEAN ARTERIAL PRESSURE; NORMAL HUMAN; PRIORITY JOURNAL; RECEPTOR UPREGULATION; SYMPATHETIC TONE; SYSTEMIC VASCULAR RESISTANCE; SYSTOLIC BLOOD PRESSURE; UPREGULATION;

ADULT; AGED; AGED, 80 AND OVER; AGING; BLOOD PRESSURE; CLONIDINE; FEMALE; HUMANS; ISOPROTERENOL; MALE; MIDDLE AGED; PHENYLEPHRINE; RECEPTORS, ADRENERGIC, ALPHA; RECEPTORS, ADRENERGIC, BETA; SEX CHARACTERISTICS; UP-REGULATION;

EID: 33750611510     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.fjc.0000246405.89380.48     Document Type: Article

References (44)

1. Fukusaki C, Kawakubo K, Yamamoto Y. Assessment of the primary effect of aging on heart rate variability in humans. Clin Auton Res. 2000;10:123-130.
2. Jones PP, Shapiro LF, Keisling GA, et al. Altered autonomic support of arterial blood pressure with age in healthy men. Circulation. 2001;104:2424-2429.
3. Esler MD, Turner AG, Kaye DM, et al. Aging effects on human sympathetic neuronal function. Am J Physiol. 1995;268:R278-285.
4. Wilkie FL, Halter JB, Prinz PN, et al. Age-related changes in venous catecholamines basally and during epinephrine infusion in man. J Gerontol. 1985;40:133-140.
5. Mazzeo RS, Rajkumar C, Jennings G, et al. Norepinephrine spillover at rest and during submaximal exercise in young and old subjects. J Appl Physiol. 1997;82:1869-1874.
6. Kingwell BA, Thompson JM, Kaye DM, et al. Heart rate spectral analysis, cardiac norepinephrine spillover, and muscle sympathetic nerve activity during human sympathetic nervous activation and failure. Circulation. 1994;90:234-240.
7. Vaz M, Rajkumar C, Wong J, et al. Oxygen consumption in the heart, hepatomesenteric bed, and brain in young and elderly human subjects, and accompanying sympathetic nervous activity. Metabolism. 1996;45:1487-1492.
8. Seals DR, Taylor JA, Ng AV, et al. Exercise and aging: autonomic control of the circulation. Med Sci Sports Exerc. 1994;26:568-576.
9. Ng AV, Callister R, Johnson DG, et al. Sympathetic neural reactivity to stress does not increase with age in healthy humans. Am J Physiol. 1994;267:H344-353.
10. Rockman HA, Koch WJ, Lefkowitz RJ. Cardiac function in genetically engineered mice with altered adrenergic receptor signaling. Am J Physiol. 1997;272:H1553-1559.
11. White M, Roden R, Minobe W, et al. Age-related changes in beta-adrenergic neuroeffector systems in the human heart. Circulation. 1994;90:1225-1238.
12. Brodde OE. Beta-adrenoceptors in cardiac disease. Pharmacol Ther. 1993;60:405-430.
13. Anderson FL, Port JD, Reid BB, et al. Myocardial catecholamine and neuropeptide Y depletion in failing ventricles of patients with idiopathic dilated cardiomyopathy. Correlation with beta-adrenergic receptor downregulation. Circulation. 1992;85:46-53.
14. Harding SE, Brown LA, Wynne DG, et al. Mechanisms of beta adrenoceptor desensitisation in the failing human heart. Cardiovasc Res. 1994;28:1451-1460.
15. Castellano M, Bohm M. The cardiac beta-adrenoceptor-mediated signaling pathway and its alterations in hypertensive heart disease. Hypertension. 1997;29:715-722.
16. Stratton JR, Cerqueira MD, Schwartz RS, et al. Differences in cardiovascular responses to isoproterenol in relation to age and exercise training in healthy men. Circulation. 1992;86:504-512.
17. Hogikyan RV, Supiano MA. Arterial alpha-adrenergic responsiveness is decreased and SNS activity is increased in older humans. Am J Physiol. 1994;266:E717-724.
18. Christ GJ, Stone B, Melman A. Age-dependent alterations in the efficacy of phenylephrine-induced contractions in vascular smooth muscle isolated from the corpus cavernosum of impotent men. Can J Physiol Pharmacol. 1991;69:909-913.
19. Goldstein DS, Zimlichman R, Stull R, et al. Plasma catecholamine and hemodynamic responses during isoproterenol infusions in humans. Clin Pharmacol Ther. 1986;40:233-238.
20. Levy WC, Cerqueira MD, Matsuoka DT, et al. Four radionuclide methods for left ventricular volume determination: comparison of a manual and an automated technique. J Nucl Med. 1992;33:763-770.
21. Randall W. Nervous Control of Cardiovascular Function. New York: Oxford University Press; 1984.
22. Dawson-Saunders B, Trapp RG. Basic and Clinical Biostatistics. Toronto: Prentice Hall of Canada; 1994.
23. Jekel JF, Katz DL, Elmore JG. Epidemiology,Biostatistics and Preventive Medicine. Toronto: WB Saunders Company; 2001.
24. Hinton PR. Statistics Explained, 2nd ed. New York: Routledge; 2004.
25. Parlow JL, Sagnard P, Begou G, et al. The effects of clonidine on sensitivity to phenylephrine and nitroprusside in patients with essential hypertension recovering from surgery. Anesth Analg. 1999;88:1239-1243.
26. Barnes RF, Raskind M, Gumbrecht G, et al. The effects of age on the plasma catecholamine response to mental stress in man. J Clin Endocrinol Metab. 1982;54:64-69.
27. Vestal RE,Wood AJ, Shand DG. Reduced beta-adrenoceptor sensitivity in the elderly. Clin Pharmacol Ther. 1979;26:181-186.
28. Lakatta EG. Age-related alterations in the cardiovascular response to adrenergic mediated stress. Fed Proc. 1980;39:3173-3177.
29. Bertel O, Buhler FR, Kiowski W, et al. Decreased Beta-adrenoreceptor responsiveness as related to age, blood pressure, and plasma catecholamines in patients with essential hypertension. Hypertension. 1980;2:130-138.
30. Benovic JL, Strasser RH, Caron MG, et al. Beta-adrenergic receptor kinase: identification of a novel protein kinase that phosphorylates the agonist-occupied form of the receptor. Proc Natl Acad Sci U S A. 1986;83:2797-2801.
31. Clark RB, Friedman J, Dixon RA, et al. Identification of a specific site required for rapid heterologous desensitization of the beta-adrenergic receptor by cAMP-dependent protein kinase. Mol Pharmacol. 1989;36:343-348.
32. Hausdorff WP, Caron MG, Lefkowitz RJ. Turning off the signal: desensitization of beta-adrenergic receptor function. Faseb J. 1990;4:2881-2889.
33. Gurevich VV, Dion SB, Onorato JJ, et al. Arrestin interactions with G protein-coupled receptors. Direct binding studies of wild type and mutant arrestins with rhodopsin, beta 2-adrenergic, and m2 muscarinic cholinergic receptors. J Biol Chem. 1995;270:720-731.
34. Lohse MJ, Benovic JL, Codina J, et al. Beta-Arrestin: a protein that regulates beta-adrenergic receptor function. Science. 1990;248:1547-1550.
35. Claing A, Laporte SA, Caron MG, et al. Endocytosis of G protein-coupled receptors: roles of G protein-coupled receptor kinases and beta-arrestin proteins. Prog Neurobiol. 2002;66:61-79.
36. Yu SS, Lefkowitz RJ, Hausdorff WP. Beta-adrenergic receptor sequestration. A potential mechanism of receptor resensitization. J Biol Chem. 1993;268:337-341.
37. Pitcher JA, Payne ES, Csortos C, et al. The G-protein-coupled receptor phosphatase: a protein phosphatase type 2A with a distinct subcellular distribution and substrate specificity. Proc Natl Acad Sci U S A. 1995;92:8343-8347.
38. Krueger KM, Daaka Y, Pitcher JA, et al. The role of sequestration in G protein-coupled receptor resensitization. Regulation of beta2-adrenergic receptor dephosphorylation by vesicular acidification. J Biol Chem. 1997;272:5-8.
39. Bohm SK, Grady EF, Bunnett NW. Regulatory mechanisms that modulate signalling by G-protein-coupled receptors. Biochem J. 1997;322:1-18.
40. Xiao RP, Tomhave ED, Wang DJ, et al. Age-associated reductions in cardiac beta1- and beta2-adrenergic responses without changes in inhibitory G proteins or receptor kinases. J Clin Invest. 1998;101:1273-1282.
41. Liggett SB, Freedman NJ, Schwinn DA, et al. Structural basis for receptor subtype-specific regulation revealed by a chimeric beta 3/beta 2-adrenergic receptor. Proc Natl Acad Sci U S A. 1993;90:3665-3669.
42. Tanaka M, Nishikawa T. Effects of clonidine premedication on the pressor response to alpha-adrenergic agonists. Br J Anaesth. 1995;75:593-597.
43. Hogikyan RV, Supiano MA. Homologous upregulation of human arterial alpha-adrenergic responses by guanadrel. J Clin Invest. 1993;91:1429-1435.
44. Castro MI. Pharmacokinetics and dynamics of intravenous, intrathecal and epidural clonidine in sheep. Anesthesiology. 1989;71:418-425.